AGP Executive Report
Last update: 9 hours agoDiabetes Care Tech: ViCentra reports real-world results in 3,918 adults using the Kaleido insulin patch pump with Diabeloop’s DBLG1 and Dexcom G6 across Germany, the Netherlands and France, showing strong time-in-range and very low hypoglycemia. Cancer & Prevention: A major global analysis links about 1 in 8 new cancer cases worldwide (2.3m in 2024) to infections, highlighting HPV, H. pylori, hepatitis B/C and others—fueling calls for stronger infection control. Medication Side Effects: New controlled research presented in Europe finds nail detachment is over 4 times more common in people using GLP-1 receptor agonists, adding dermatology to the growing list of drug effects to watch. France Health Policy & Costs: October brings household changes including higher gas prices and expanded fuel aid, plus a new social leasing scheme for heat pumps—relevant for health via energy affordability. Public Health Context: Student and public-sector unrest continues across France, with school blockades and clashes that could disrupt learning and access to services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
